Artiva Biotherapeutics (ARTV) Receivables (2023 - 2024)
Historic Receivables for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $79000.0.
- Artiva Biotherapeutics' Receivables fell 8873.04% to $79000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $79000.0, marking a year-over-year decrease of 8873.04%. This contributed to the annual value of $146000.0 for FY2024, which is 9169.51% down from last year.
- Latest data reveals that Artiva Biotherapeutics reported Receivables of $79000.0 as of Q3 2025, which was down 8873.04% from $30000.0 recorded in Q2 2025.
- In the past 5 years, Artiva Biotherapeutics' Receivables registered a high of $1.8 million during Q4 2023, and its lowest value of $30000.0 during Q2 2025.
- Moreover, its 3-year median value for Receivables was $234000.0 (2025), whereas its average is $629857.1.
- Examining YoY changes over the last 5 years, Artiva Biotherapeutics' Receivables showed a top increase of 8873.04% in 2025 and a maximum decrease of 9794.66% in 2025.
- Artiva Biotherapeutics' Receivables (Quarter) stood at $1.8 million in 2023, then tumbled by 91.7% to $146000.0 in 2024, then crashed by 45.89% to $79000.0 in 2025.
- Its last three reported values are $79000.0 in Q3 2025, $30000.0 for Q2 2025, and $234000.0 during Q1 2025.